Paper · 831755
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.
Peto R and 9 others. Br J Cancer, 1977. Cited by 8,246 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Papers, record 831755. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/831755
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Evaluation | Major topic |
| Statistics as Topic | Major topic |
| Humans | |
| Leukemia | |
| Methods | |
| Mortality | |
| Multiple Myeloma | |
| Prognosis | |
| Remission, Spontaneous | |
| Research Design | |
| Time Factors |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00188149 | Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET | Background | ClinicalTrials.gov | |
| NCT06176638 | Resettled Refugee Families for Healing | Background | ClinicalTrials.gov |
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,594,339 | Statistical methods for the identification and use of prognostic factors. | Int J Cancer | 1974 | https://conductscience.org/library/papers/4594339 | PubMed |
| 2 | 4,182,654 | Active immunotherapy for acute lymphoblastic leukaemia. | Lancet | 1969 | https://conductscience.org/library/papers/4182654 | PubMed |
| 3 | 5,910,392 | Evaluation of survival data and two new rank order statistics arising in its consideration. | Cancer Chemother Rep | 1966 | https://conductscience.org/library/papers/5910392 | PubMed |
| 4 | 1,056,801 | BCG in the treatment of acute lymphocytic leukemia. | Blood | 1975 | https://conductscience.org/library/papers/1056801 | PubMed |
| 5 | 4,793,138 | Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. | Biometrics | 1973 | https://conductscience.org/library/papers/4793138 | PubMed |
Cited by1,355
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8,246 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,362,705 | Electrical resistance measurement in feline cutaneous squamous cell carcinoma treated with electrochemotherapy: a pilot study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42362705 | PubMed |
| 42,026,499 | Aspartate aminotransferase-to-lymphocyte ratio predicts in-hospital mortality in patients with severe fever with thrombocytopenia syndrome: a multicenter retrospective cohort study. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/42026499 | PubMed |
| 41,985,005 | Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-cell acute lymphoblastic leukemia. | Blood Adv | 2026 | https://conductscience.org/library/papers/41985005 | PubMed |
| 41,984,995 | Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes. | Blood Adv | 2026 | https://conductscience.org/library/papers/41984995 | PubMed |
| 41,731,415 | Retention and predictors of loss-to-follow-up among patients on antiretroviral therapy in the Test-and-Treat Era: evidence from a retrospective cohort study in Maputo, Mozambique. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/41731415 | PubMed |
| 41,729,085 | Prognostic Value of a Semi-Quantitative Score Based on 123 I-MIBG SPECT/CT in Pediatric Patients With Stage 4 High-Risk Neuroblastoma After Induction Therapy. | Clin Nucl Med | 2026 | https://conductscience.org/library/papers/41729085 | PubMed |
| 41,697,469 | RET germline mutations drive tumorigenesis but not tumor aggressiveness in MEN 2. | Endocrine | 2026 | https://conductscience.org/library/papers/41697469 | PubMed |
| 41,495,464 | Exploration of refined humane endpoints for melioidosis in BALB/c mice. | Lab Anim (NY) | 2026 | https://conductscience.org/library/papers/41495464 | PubMed |
| 41,437,255 | Non-housing assets and all-cause mortality in middle-aged and older Chinese adults: a National cohort study. | Popul Health Metr | 2025 | https://conductscience.org/library/papers/41437255 | PubMed |
| 41,143,597 | Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group. | Clin Cancer Res | 2026 | https://conductscience.org/library/papers/41143597 | PubMed |
1 to 10 of 1,355
See all 1,355 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/831755
GET https://conductscience.org/api/papers/v1/831755/cited_by?page=2